Household MRSA Colonization, Transmission, and Infection: A Multidisciplinary Approach Presented by Manuel Bramble Principal Investigator: Dr. Ebbing Lautenbach.

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

Working in a CMS? Know the Facts About Community Associated MRSA (CA-MRSA)
MRSA Community Acquired Methicillin Resistant Staphylococcus Aureus
Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
The Facts About MRSA.
What are Staph & MRSA? Staph (Staphlococcus aureus)
Commons.wikimedia.org Introduction  Staphylococcus aureus (SA) is a gram- positive cocci bacterium. The Methicillin- resistant SA (MRSA) is a strain resistant.
Methicillin-Resistant Staphylococcus aureus (MRSA) Information provided by the Pickaway County General Health District.
MRSA.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
Methicillin-Resistant Staphylococcus Aureus
Overview of Outbreak Investigations. Goals The goals of this presentation are to: Provide a general overview of the basic steps of disease outbreak investigations.
Methicillin-resistant staphylococcus aureus By Jackson Cullop
MRSA Methicillin Resistant Staphylococcus Aureus
The Ugly face of MRSA (Methicillin Resistant Staphylococcus aureus) MRSA is a staph aureus infection that has become resistant to the class of antibiotics,
COMMUNITY ACQUIRED MRSA MARGARET TEITELBAUM RN,BSN,CSN SCHOOL NURSE/HEALTH EDUCATOR WESTFIELD HIGH SCHOOL.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Live, Learn, Work and Play
Information on Staphlococcus aureus and Resistant Staphlococcus aureus (MRSA) Prepared by: Kathryn Billings.
MRSA PREPARED BY SARA ABUHIMED. Methicillin-resistant Staphylococcus Aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These.
Methicillin-Resistant Staphylococcus aureus Infections in California Hospital Patients, 1999 – 2006 Mary Tran, PhD, MPH Niya Fong, BS Microbiology California.
Community- Associated MRSA Maha Assi, MD, MPH. MRSA Hits the Media October 16, 2007 October 16, 2007 Lead story on MRSA Lead story on MRSA “superbug killing.
Soft Tissue Infections
MRSA in Corrections Danae Bixler, MD, MPH
MRSA and VRE in a Rural Community Hospital Graduation Project 2008 Mehvish Ally.
(methicillin-resistant Staphylococcus aureus)
Infectious Diseases in Industry. Nancy V. Rodway MD MS MPH Medical Director, Occupational Services, Ambulatory Centers and Employee Health.
Mandatory Inservice INFECTION CONTROL. At the completion of this module the participant will be able to:  Define Standard Precautions  Discuss The Chain.
NOSOCOMIAL INFECTIONS Phase 1: Testing the efficacy of Nano-Mg (OH) 2 Dorothea A. Dillman PhD, RN, CCRN, LNC.
Methicillin-resistant Staphylococcus Aureus (MRSA) By: Aaron Mohr, Taylor Host, and Kristen Sposetta.
Prevalence of Methicillin-resistant Staphylococcus aureus in El Oro Province, Ecuador Student Researchers: Christopher A. Monte, Beatrice R. Soderholm.
The Super Bug? Alexander L. Brzezny, MD, MPH Health Officer Grant County Health District September 4 th, 2007.
Is The Prevalence of Staphylococcus aureus Increasing Among York College Students? By: Angel Newson Department of Biological Sciences, York College of.
MRSA 2006 Community Infection Control Nurses
Community Acquired MRSA CA-MRSA Margaret Teitelbaum School Nurse/Health Educator Westfield High School.
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
Prevalence of Methicillin-Resistant Staphylococcus aureus in 4A and 5A High Schools in Texas UIL Region IV Fall 2004 By Carolina Espinoza Public Health.
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center.
Definitions Infection control Infectious disease Pathogens.
The Carriage of Staphylococcus aureus And The Prevalence of Virulence Genes In College Students Sachiya Ridore Mentor: Dr. Gray, Department of Biology,
Understanding Methicillin-Resistant Staphylococcus aureus
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Staphylococcus aureus Skin Infections
MRSA (Methicillin-resistant Staphylococcus Aureus) By: Matt Steer, Dylan Scott, Jordan Wolford, Kaylla Vaughn.
Life and Times of: Methicillin Resistant Staphylococcus Aureus (MRSA) Group 3.
MRSA (Methacillin- Resistant Staph Aureus) Deborah Moore, MS, APRN, BC VT PHS Regional Administrator.
KJO Hospital Infection Control Local 2176/2097 Ross Ibabao/ICCo.
MRSA (Methicillin-resistant Staphylococcus aureus ) Information and self-care.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
Staph Infections. What is staph? Staphylococcus aureus, often referred to simply as “staph,” are bacteria commonly carried on the skin or in the nose.
MRSA.
MRSA Jerome, Taylor, and Tate. Statistics In the US in 2003, there were an estimated 12 million doctor or emergency room visits for skin and soft tissue.
Questions and Answers about Methicillin-Resistant Staphylococcus Aureus (MRSA) in Schools Centers For Disease Control and Prevention
Nosocomial Antibiotic Resistant Organisms
How To Design a Clinical Trial
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
HAI August 30, 2017.
HAI January 24, 2018.
By Carolina Espinoza Public Health Internship - Spring 2005
HAI Sept. 25, 2017.
MRSA=Methicillin resistant Staphylococcus aureus
By Carolina Espinoza Public Health Internship - Spring 2005
Presentation transcript:

Household MRSA Colonization, Transmission, and Infection: A Multidisciplinary Approach Presented by Manuel Bramble Principal Investigator: Dr. Ebbing Lautenbach Co-Principal Investigators: Dr. Joshua Metlay and Dr. Jeffrey Weiser

Background

What is MRSA?  MRSA stands for Methicillin- Resistant Staphylococcus aureus (“staph aureus” for short)  Even though the bacteria is referred to as methicillin-resistant, it is resistant to many antibiotics, which makes it particularly hard to treat

Who cares?  The percentage of S. aureus isolates that are methicillin-resistant rose from 22% in 1995 to 57% in 2001 (Boucher et al., 2008)  MRSA now accounts for over 60% of S. aureus isolates in United States ICUs (Boucher et al., 2008)  MRSA infections cause around 19,000 American patient deaths annually (Boucher et al., 2008)  In 2003, the associated incremental cost of staphylococcal disease was $14.5 billion, and 60% of the infections were caused by MRSA (Kluytmans et al., 2009)

Colonization vs. Infection  Colonization- when the bacteria are present in the body without causing illness. The most common sites for MRSA colonization are in warm, moist places, such as the nostrils, groin, and armpits.  Infection- indicated by the presence of clinical symptoms such as fever, redness, pain, and swelling. Infection occurs most often in wounds or other open skin.

Healthcare Associated (HA-MRSA) vs. Community Associated (CA-MRSA) There are two different types of MRSA, and they differ based on where they are most prevalent.  HA-MRSA is found in healthcare settings such as hospitals or long-term care facilities  CA-MRSA is found in the community, outside of health care facilities (includes the home)

How is MRSA spread? Most of what we know about MRSA is from the hospital environment. Much less is known about transmission in the home. However, some mechanisms have been suggested: 1. Direct contact with infected or colonized host -human-to-human contact 2. Contaminated intermediate surfaces -hand towels -faucets -tub/shower 3. Airborne fluid droplets

Pets’/Animals’ Roles in MRSA Transmission  In several studies, it has been found that farm owners, veterinary clinicians, and pet owners are at greater risk for MRSA infection  In particular, there have been documented MRSA transmission to humans from:  Dogs  Cats  Horses  Pigs  It is often noted that animals, especially pets, can serve as “reservoirs of infection”

The Study

Two Approaches 1.The first phase of the study is a prospective cohort study. During this phase, all household members enrolled in the study will undergo regular sampling for MRSA colonization over time. 2.The second phase is a randomized control trial. The purpose of this phase is to compare the effectiveness of two decolonization interventions.

Main Goals of the Study: 1) To identify the reasons that some people are more likely than others to have MRSA on their skin and how MRSA may spread from person to person 2) To identify possible strategies to prevent MRSA spread and infection 3) To determine how MRSA colonization is affected by co-existing S. pneumoniae colonization

Recruitment Patients are to be enrolled at four hospitals:  Hospital of the University of Pennsylvania (HUP),  Penn Presbyterian Medical Center (PPMC)  Children’s Hospital of Philadelphia (CHOP)  Penn State Hershey Medical Center (HMC) All adults and children receiving care in the emergency departments (EDs) for newly diagnosed skin or soft tissue infection (SSTI) will be approached for the study. Enrollment will be completed upon medical confirmation of MRSA as the cause of infection.

What is required of study subjects? All members of each enrolled household will: 1.Undergo sampling for MRSA and S. pneumoniae colonization at enrollment 2.Receive one initial home visit to receive swab supplies and one additional home visit for S. pneumoniae sampling at 3 month follow-up 3.Undergo regular self-collected sampling for MRSA colonization over the entire 6-month period of follow-up. 4.Participate in bi-monthly telephone interviews about lifestyle behaviors Each household member will be compensated $5 per swab.

My Contributions

The Brochure  The Brochure is designed to ensure that everyone being approached about the study is fully aware of what being a part of the study entails. The information they receive will allow them to make a well- informed decision before they sign the consent form.  I wrote and designed the brochure (with guidance from Pam Tolomeo, the Project Manager, and Dr. Lautenbach, the Principal Investigator)

Data Collection Forms  During the initial and follow-up visits, data collection forms will be filled out in order to record information concerning the study.  I went through all of the data collection forms and edited them. This helped to ensure that the data collection forms were: -legible/understandable -practical -relevant to the study -in concordance with the grant

Narrative Review  Dr. Lautenbach will be submitting a new grant that will investigate the role of pets in MRSA transmission within the household.  I reviewed all of the available medical literature on this topic, and I am in the process of will be provide critical background information for this grant.  The literature review is also being written up as a narrative review on the topic of the role of pets in MRSA household transmission. This work will be submitted as a scientific manuscript with me as lead author.

What I’ve Learned  Process of proposing, organizing, and maintaining a study  Informed consent  Data entry  Recruitment  Writing and publishing one’s research  MRSA

Acknowledgements  Dr. Ebbing Lautenbach  Dr. Joshua Metlay  Pam Tolomeo  Joanne  Shanta  SUMR scholars and staff  LDI  CHERP  Provost’s Diversity Fund  AHRQ

References Boucher, H. W. and G. R. Corey (2008). "Epidemiology of methicillin-resistant Staphylococcus aureus." Clin Infect Dis 46 Suppl 5: S344-9 Kluytmans, J. and M. Struelens (2009). "Meticillin resistant Staphylococcus aureus in the hospital." BMJ 338: b364.

Thanks for listening!